QVT Financial LP 4
4 · Roivant Sciences Ltd. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Roivant (ROIV) QVT Financial (Director by Deputization) Sells 1.23M Shares
What Happened QVT Financial LP (reported as "Director by Deputization") sold a total of 1,225,784 common shares of Roivant Sciences (ROIV) in a series of open‑market dispositions between Feb 11 and Feb 13, 2026. The sales ranged from $26.49 to $26.76 per share, generating aggregate proceeds of approximately $32.66 million. These were outright sales (S), not purchases or option exercises — typically routine disposition activity by an investment manager rather than an executive buy signal.
Key Details
- Transactions:
- 2026-02-11: 425,000 shares @ $26.67 = $11,334,750
- 2026-02-12: 150,000 shares @ $26.72 = $4,008,000
- 2026-02-12: 275,000 shares @ $26.76 = $7,359,000
- 2026-02-13: 150,784 shares @ $26.49 = $3,994,268
- 2026-02-13: 225,000 shares @ $26.50 = $5,962,500
- Aggregate sold: 1,225,784 shares for ~$32,658,518.
- Shares owned after transaction: QVT (and related entities) may be deemed to beneficially own 25,161,237 common shares following these trades (per footnote F1).
- Footnote F2: QVT provides advisory services for related entities and disclaims beneficial ownership except to the extent of any pecuniary interest — institutional reporting, not necessarily direct control.
- Filing: Form 4 filed Feb 13, 2026 covering trades Feb 11–13; this filing date is within the SEC’s typical two‑business‑day reporting window.
Context
- This is institutional sell activity (an investment manager reporting sales on behalf of related accounts), not an executive insider purchase. Sales do not necessarily indicate negative company prospects — they can reflect portfolio rebalancing, liquidity needs, or other non‑company‑specific reasons.
- No derivatives, option exercises, gifts, or awards were reported in this Form 4 — only open‑market sales.
Insider Transaction Report
Form 4
QVT Financial LP
Other
Transactions
- Sale
Common Shares
[F1][F2]2026-02-11$26.67/sh−425,000$11,334,750→ 15,928,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-02-12$26.72/sh−150,000$4,008,000→ 15,778,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-02-12$26.76/sh−275,000$7,359,000→ 15,503,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-02-13$26.49/sh−150,784$3,994,268→ 15,352,329 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-02-13$26.50/sh−225,000$5,962,500→ 15,127,329 total(indirect: Held by QVT Financial Investment Cayman Ltd.)
Footnotes (2)
- [F1]Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 25,161,237 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.
- [F2]QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Meg Eisner|2026-02-13